UK's MHRA Looks Beyond Brexit Transition Period

Working To Ensure Continuity Of Drug Regulation After 31 December

Brexit_Pills
The MHRA is considering UK drug regulation post-Brexit • Source: Shutterstock

More from Regulation

More from Policy & Regulation